Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome-Reference-Cited by-同舟云学术

Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome

Published:2021-10-22 Issue: Volume: Page:
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Lv Wen-He,Dong Jian-Zeng,Du Xin,Hu Rong,He Liu,Long De-Yong,Sang Cai-Hua,Jia Chang-Qi,Feng Li,Li Xu,Ning Man,Chen Xuan,Cui Yi-Kai,Tang Ri-Bo^ORCID,Ma Chang-Sheng

Funder

National Key Research and Development Program of China

Beijing Municipal Science and Technology Commission

ZHONGNANSHAN MEDICAL FOUNDATION OF GUANGDONG PROVINCE

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-021-02588-z.pdf

Reference19 articles.

1. Bertrand ME, Legrand V, Boland J, Fleck E, Bonnier J, Emmanuelson H et al (1998) Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation 98(16):1597–1603. https://doi.org/10.1161/01.cir.98.16.1597

2. ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S et al (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel Trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet 367(9526):1903–1912. https://doi.org/10.1016/S0140-6736(06)68845-4

3. De Luca L, Rubboli A, Bolognese L, Gonzini L, Urbinati S, Murrone A et al (2020) Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study. BMJ Open 10(12):e41044. https://doi.org/10.1136/bmjopen-2020-041044

4. Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377(16):1513–1524. https://doi.org/10.1056/NEJMoa1708454

5. Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G et al (2019) Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet 394(10206):1335–1343. https://doi.org/10.1016/S0140-6736(19)31872-0

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrum of Non-Obstructive Coronary Artery Disease and Its Relationship with Atrial Fibrillation;Journal of Clinical Medicine;2024-08-21